Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
CANCER BIOMARKERS, cilt.27, sa.1, ss.11-17, 2020 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 27 Sayı: 1
- Basım Tarihi: 2020
- Doi Numarası: 10.3233/cbm-190085
- Dergi Adı: CANCER BIOMARKERS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
- Sayfa Sayıları: ss.11-17
- Anahtar Kelimeler: Breast cancer, neoadjuvant chemotherapy, pathological complete response, long non-coding RNAs, blood plasma, NONCODING RNA H19, THERAPY, PLASMA, TUMOR
- İstanbul Üniversitesi Adresli: Evet
Özet
BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC).